Title:
The medication regimen of an S1P receptor agonist
Document Type and Number:
Japanese Patent JP5941110
Kind Code:
B2
Abstract:
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.
More Like This:
| JP2008542205 | 4-Method for producing biphenylyl azetidine-2-one |
| JP6673218 | Dihydronaphthalene derivative |
| JPH07502257 | [Title of Invention] Antibiotic compound |
Inventors:
Eric, Legangneus
Application Number:
JP2014191541A
Publication Date:
June 29, 2016
Filing Date:
September 19, 2014
Export Citation:
Assignee:
Novartis Age
International Classes:
A61K31/397; A61P25/00; A61P37/06; A61P43/00; C07D205/04
Domestic Patent References:
| JP2007503468A | ||||
| JP2007509970A | ||||
| JP2009507047A | ||||
| JP2008150370A | ||||
| JP2010524989A |
Foreign References:
| WO2007048219A1 | ||||
| WO2008128739A1 |
Other References:
ADACHI, K. et al,FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate rec,Perspect. Medicin. Chem.,2007年,Vol.1,p.11-23
BUDDE, K. et al,First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients,J. Am. Soc. Nephrol.,2002年,Vol.13, No.4,p.1073-1083
BUDDE, K. et al,First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients,J. Am. Soc. Nephrol.,2002年,Vol.13, No.4,p.1073-1083
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Tomohiro Maruyama
Yasuhito Suzuki
Norio Omori
Tomohiro Maruyama
Yasuhito Suzuki